FOXO3 and cancer: In the present study, we are the first to report the anti-cancer effect of Elaiophylin in in vitro, ex vivo and in vivo UM models, which is mediated through mitophagy inhibition, and the modulation of SIRT1-FoxO3a signaling axis.